Wine is one of the utmost popular drinks consumed worldwide. The escalating demand for wine, because of its unusual taste and health assistances is one of the key aspects boosting the growth of the global wine market. The global wine mar…
BMI View: Growth in Lebanon's pharmaceutical market will be heavily driven by the sales of high-value
prescription medicines thanks to an aging population, relatively high per capita spending and rising disease
burden. Furthermore, the Health Ministry's recent move to increase healthcare coverage for citizens over
the age of 64 highlights the country's commitment to improving healthcare quality and access across the
country. However, ongoing regional instability and Lebanon's own economic stagnation will continue to
dampen multinational drugmakers' interest in the market.
Headline Expenditure Projections
? Pharmaceuticals: LBP2.47trn (USD1.64bn) in 2015 to LBP2.60trn (USD1.72bn) in 2016; +5.5% in
local currency and US dollar terms. Forecast revised downwards slightly from last quarter.
? Healthcare: LBP5.04trn (USD3.34bn) in 2015 to LBP5.27trn (USD3.50bn) in 2016; +4.8% in local
currency and US dollar terms. Forecast unchanged from last quarter.